“An open-label, pilot study to evaluate the benefits of using lyophilized human milk-derived nutritional product (NeoLact 70 – 1.55 g) as an immune-nutritional supplement in premature infants discharged from NICU”, Indian J Child Health, vol. 8, no. 12, pp. 404–407, Dec. 2021, doi: 10.32677/ijch.v8i12.3213.